Decision to Issue KRW 15 Billion Unsecured Private Convertible Bonds - Conversion Price KRW 10,782 (2.8% Premium to Current Price), Potential Dilution 11.31% | KOREA PHARMA(032300)

Decision to issue KRW 15 billion unregistered unsecured private convertible bonds (coupon 0%, maturity 0%, maturity date May 28, 2031)
Conversion price of KRW 10,782 (based on the higher of 1-month, 1-week, and latest VWAP prior to board resolution), representing a 2.8% premium over the current price of KRW 10,490
Shares to be issued upon conversion: 1,391,207 shares (11.31% of outstanding shares); total potential dilution including existing CBs is 22.40%
All proceeds to be used for operating funds (R&D and productivity enhancement): KRW 2.5B in 2026, KRW 2.5B in 2027, KRW 10B from 2028 onward
Bondholders have a put option exercisable every 3 months starting 30 months after issuance (redemption yield 0.0% p.a.)
Issuer and its designees may exercise a call option for up to 40% of each holder's initial investment every 3 months between 12 and 30 months after issuance (purchase price includes 0.1% p.a. premium)

ADVERTISEMENT (250px+)